Patents by Inventor Mariano Ruffo

Mariano Ruffo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11701463
    Abstract: There is provided an IV infusion set comprising a patient access configured to connect to a vascular system of a patient, a source of medical fluid, an infusion line having one first end configured to connect to the source of medical fluid and one opposite second end configured to deliver the medical fluid towards the patient access, an infusion apparatus arranged on the infusion line, a sensor configured to emit a pressure signal indicative of a pressure of a medical fluid in the infusion line, and a control unit configured to receive the pressure signal and to determine a patient signal indicative of a vital signal of the patient based on the pressure signal. The IV infusion set further comprises a compliance element configured to attenuate pressure variations of medical fluid the infusion line, and a resistance element configured to reflect pressure waves moving along the infusion line.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: July 18, 2023
    Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SA
    Inventors: Paolo Rovatti, Mariano Ruffo, David Stefani, Elena Grandi
  • Publication number: 20220249025
    Abstract: Non-invasive heartbeat sensor for determining a heart rate in a conduit of an extracorporeal blood treatment apparatus, comprising one source for directing an optical signal towards the blood flowing in the segment; one detector for receiving an optical informative signal comprising the signal emitted by said source after passing the blood, and emitting respective output signal; a controller receiving the respective output signal and retrieving a heartbeat frequency and a heart rate value, based on the output signal, wherein the informative signal is altered by flow perturbation of the blood partially generated by the flow impulses originated by the heart.
    Type: Application
    Filed: September 18, 2020
    Publication date: August 11, 2022
    Inventors: Paolo Rovatti, Mariano Ruffo, David Stefani
  • Publication number: 20210001043
    Abstract: There is provided an IV infusion set comprising a patient access configured to connect to a vascular system of a patient, a source of medical fluid, an infusion line having one first end configured to connect to the source of medical fluid and one opposite second end configured to deliver the medical fluid towards the patient access, an infusion apparatus arranged on the infusion line, a sensor configured to emit a pressure signal indicative of a pressure of a medical fluid in the infusion line, and a control unit configured to receive the pressure signal and to determine a patient signal indicative of a vital signal of the patient based on the pressure signal. The IV infusion set further comprises a compliance element configured to attenuate pressure variations of medical fluid the infusion line, and a resistance element configured to reflect pressure waves moving along the infusion line.
    Type: Application
    Filed: December 21, 2018
    Publication date: January 7, 2021
    Inventors: Paolo ROVATTI, Mariano RUFFO, David STEFANI, Elena GRANDI
  • Patent number: 10124108
    Abstract: An apparatus for extracorporeal blood treatment (1) is described, comprising a treatment unit (3) having at least a first chamber (4) and at least a second chamber (5) separated from one another by a semi-permeable membrane (6); at least a blood removal line (7) connected to an inlet port (4a) of the first chamber (4) and predisposed to remove blood from a patient (P); at least a blood return line (8) connected to an outlet port (4b) from the first chamber (4) and predisposed to return treated blood to the patient (P), wherein the blood removal line (7), the blood return line (8) and the first chamber (4) are part of an extracorporeal blood circuit (2); at least a peristaltic pump (9) operating at the extracorporeal blood circuit (2) for moving the blood in the circuit; at least a pressure sensor (13, 14) associated to the extracorporeal blood circuit (2) and configured to enable determining pressure values in the extracorporeal blood circuit (2); at least a fluid drainage line (23) connected to an outlet por
    Type: Grant
    Filed: July 4, 2014
    Date of Patent: November 13, 2018
    Assignee: GAMBRO LUNDIA AB
    Inventors: David Stefani, Mariano Ruffo
  • Publication number: 20160144096
    Abstract: An apparatus for extracorporeal blood treatment (1) is described, comprising a treatment unit (3) having at least a first chamber (4) and at least a second chamber (5) separated from one another by a semi-permeable membrane (6); at least a blood removal line (7) connected to an inlet port (4a) of the first chamber (4) and predisposed to remove blood from a patient (P); at least a blood return line (8) connected to an outlet port (4b) from the first chamber (4) and predisposed to return treated blood to the patient (P), wherein the blood removal line (7), the blood return line (8) and the first chamber (4) are part of an extracorporeal blood circuit (2); at least a peristaltic pump (9) operating at the extracorporeal blood circuit (2) for moving the blood in the circuit; at least a pressure sensor (13, 14) associated to the extracorporeal blood circuit (2) and configured to enable determining pressure values in the extracorporeal blood circuit (2); at least a fluid drainage line (23) connected to an outlet por
    Type: Application
    Filed: July 4, 2014
    Publication date: May 26, 2016
    Inventors: David Stefani, Mariano Ruffo